Artivion Inc.

19.21+0.3300+1.75%Vol 172.19K1Y Perf -34.22%
Jul 1st, 2022 16:00 DELAYED
BID17.52 ASK20.29
Open18.80 Previous Close18.88
Pre-Market- After-Market19.21
 - -  - -%
Target Price
31.95 
Analyst Rating
Strong Buy 1.50
Potential %
66.32 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★+     53.26
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★+     42.13
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
27.54 
Earnings Rating
Market Cap772.26M 
Earnings Date
4th Aug 2022
Alpha-0.01 Standard Deviation0.12
Beta1.48 

Today's Price Range

18.6919.49

52W Range

15.4429.13

5 Year PE Ratio Range

-259.50684.30

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Buy
Performance
1 Week
-0.93%
1 Month
0.63%
3 Months
-11.31%
6 Months
-5.60%
1 Year
-34.22%
3 Years
-36.47%
5 Years
-3.71%
10 Years
261.09%

TickerPriceChg.Chg.%
AORT19.210.33001.75
AAPL138.932.21001.62
GOOG2 181.62-5.8300-0.27
MSFT259.582.75001.07
XOM87.551.91002.23
WFC39.920.75001.91
JNJ179.522.01001.13
FB196.640.99000.51
GE63.54-0.1300-0.20
JPM114.051.44001.28
Earnings HistoryEstimateReportedSurprise %
Q01 20220.000.03-
Q04 2021-0.110.00100.00
Q03 20210.050.26420.00
Q02 2021-0.05-0.06-20.00
Q01 2021-0.11-0.0827.27
Q04 2020-0.020.201.10K
Q03 2020-0.010.131.40K
Q02 2020-0.03-0.0233.33
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date4th Aug 2022
Estimated EPS Next Report0.09
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume172.19K
Shares Outstanding40.20K
Shares Float31.48M
Trades Count2.78K
Dollar Volume3.30M
Avg. Volume232.60K
Avg. Weekly Volume245.56K
Avg. Monthly Volume236.10K
Avg. Quarterly Volume216.14K

Artivion Inc. (NYSE: AORT) stock closed at 19.21 per share at the end of the most recent trading day (a 1.75% change compared to the prior day closing price) with a volume of 172.19K shares and market capitalization of 772.26M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 1200 people. Artivion Inc. CEO is James Patrick Mackin.

The one-year performance of Artivion Inc. stock is -34.22%, while year-to-date (YTD) performance is -5.6%. AORT stock has a five-year performance of -3.71%. Its 52-week range is between 15.44 and 29.13, which gives AORT stock a 52-week price range ratio of 27.54%

Artivion Inc. currently has a PE ratio of -49.70, a price-to-book (PB) ratio of 2.62, a price-to-sale (PS) ratio of 2.54, a price to cashflow ratio of 324.40, a PEG ratio of 2.32, a ROA of -1.95%, a ROC of -0.76% and a ROE of -5.18%. The company’s profit margin is -4.95%, its EBITDA margin is 9.10%, and its revenue ttm is $304.96 Million , which makes it $7.59 revenue per share.

Of the last four earnings reports from Artivion Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.09 for the next earnings report. Artivion Inc.’s next earnings report date is 04th Aug 2022.

The consensus rating of Wall Street analysts for Artivion Inc. is Strong Buy (1.5), with a target price of $31.95, which is +66.32% compared to the current price. The earnings rating for Artivion Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Artivion Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Artivion Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 26.40, ATR14 : 0.88, CCI20 : 90.46, Chaikin Money Flow : -0.07, MACD : 0.15, Money Flow Index : 75.66, ROC : 18.14, RSI : 57.76, STOCH (14,3) : 77.08, STOCH RSI : 0.65, UO : 50.05, Williams %R : -22.92), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Artivion Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
3 (75.00 %)
3 (75.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (25.00 %)
1 (25.00 %)
1 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.50
Strong Buy
1.50
Strong Buy
1.50

Artivion Inc.

Cryolife Inc is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures focused on aortic repair. The company has two reportable segments namely Medical devices and Preservation Services. The Medical Devices segment includes revenues from sales of BioGlue, On-X products, JOTEC products, CardioGenesis cardiac laser therapy, PerClot, and PhotoFix. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular tissues. It generates a majority of its revenue from the Medical Devices segment. Geographically, the company generates a majority of its revenue from the United States.

CEO: James Patrick Mackin

Telephone: +1 770 419-3355

Address: 1655 Roberts Boulevard North West, Kennesaw 30144, GA, US

Number of employees: 1 200

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

67%33%

Bearish Bullish

67%33%

TipRanks News for AORT

Thu, 14 Apr 2022 18:35 GMT Analysts Have Conflicting Sentiments on These Healthcare Companies: BioCryst (BCRX), Artivion (AORT) and Longeveron (LGVN)

- TipRanks. All rights reserved.

Fri, 25 Mar 2022 09:45 GMT Artivion (AORT) Gets a Buy Rating from Needham

- TipRanks. All rights reserved.

News

Stocktwits